Li et al. previously reported that FTO downregulates the expression of ASB2 and RARA by reducing their m6A levels, thereby promoting the survival/proliferation of AML cells and inhibiting differentiation and apoptosis [30]. This evidence concerns the gene ASB2 and acute myeloid leukemia.